GLP-1 RAs might be useful for the treatment of people with T2DM and overweight/obesity, since they have been shown to be beneficial in achieving weight loss targets, an essential component of the therapeutic strategy of T2DM [3]. This evidence concerns the gene GLP1R and Obesity.